|
US2616927A
(en)
|
1950-05-12 |
1952-11-04 |
Minnesota Mining & Mfg |
Fluorocarbon tertiary amines
|
|
US4452818A
(en)
|
1982-03-19 |
1984-06-05 |
Haidt Sterling J |
Extraocular method of treating the eye with liquid perfluorocarbons
|
|
US5077036A
(en)
|
1986-01-14 |
1991-12-31 |
Alliance Pharmaceutical Corp. |
Biocompatible stable fluorocarbon emulsions for contrast enhancement and oxygen transport comprising 40-125% wt./volume fluorocarbon combined with a phospholipid
|
|
JPS6452722A
(en)
|
1987-05-01 |
1989-02-28 |
Anjierini Pharmaceut Inc |
Ophthalmic composition
|
|
US5518731A
(en)
|
1990-09-27 |
1996-05-21 |
Allergan, Inc. |
Nonaqueous fluorinated drug delivery vehicle suspensions
|
|
US6458376B1
(en)
|
1990-09-27 |
2002-10-01 |
Allergan, Inc. |
Nonaqueous fluorinated drug delivery suspensions
|
|
US5326566A
(en)
|
1991-05-17 |
1994-07-05 |
Bristol-Myers Squibb Company |
Use of dibutyl adipate and isopropyl myristate in topical and transdermal products
|
|
FR2679150A1
(fr)
|
1991-07-17 |
1993-01-22 |
Atta |
Preparations comprenant un fluorocarbure ou compose hautement fluore et un compose organique lipophile-fluorophile, et leurs utilisations.
|
|
US6602900B2
(en)
|
1992-09-21 |
2003-08-05 |
Allergan, Inc. |
Cyclopentane heptan(ENE)oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents
|
|
US5336175A
(en)
|
1992-10-29 |
1994-08-09 |
Mames Robert N |
Method for the treatment of retinal detachments
|
|
US5370313A
(en)
|
1994-01-10 |
1994-12-06 |
Beard; Walter C. |
Sterile liquid dispenser
|
|
DE4405627A1
(de)
|
1994-02-22 |
1995-08-24 |
Hoechst Ag |
Fluorkohlenwasserstoffe enthaltende Ölemulsionen
|
|
FR2720943B1
(fr)
|
1994-06-09 |
1996-08-23 |
Applic Transferts Technolo |
Emulsions inverses stables à forte concentration en composé(s) fluoré(s) et leur utilisation pour l'administration pulmonaire de médicaments et pour la fabrication d'émulsions multiples.
|
|
US6294563B1
(en)
|
1994-10-27 |
2001-09-25 |
Allergan Sales, Inc. |
Combinations of prostaglandins and brimonidine or derivatives thereof
|
|
US5696164A
(en)
|
1994-12-22 |
1997-12-09 |
Johnson & Johnson Consumer Products, Inc. |
Antifungal treatment of nails
|
|
US5874481A
(en)
|
1995-06-07 |
1999-02-23 |
Alliance Pharmaceutical Corp. |
Fluorochemical solutions for the delivery of lipophilic pharmaceutical agents
|
|
US5667809A
(en)
|
1995-06-07 |
1997-09-16 |
Alliance Pharmaceutical Corp. |
Continuous fluorochemical microdispersions for the delivery of lipophilic pharmaceutical agents
|
|
DE19536504C2
(de)
|
1995-09-29 |
1999-09-23 |
H Meinert |
Verwendung fluorierter Alkane
|
|
US5874469A
(en)
|
1996-01-05 |
1999-02-23 |
Alcon Laboratories, Inc. |
Fluoroalkyl hydrocarbons for administering water insoluble or unstable drugs
|
|
FR2752161B1
(fr)
|
1996-08-07 |
1998-09-25 |
Atta |
Emulsions multiples de type hydrocarbure-dans-eau-dans- fluorocarbone pour le transport de substances medicamenteuses hydrophiles et/ou lipophiles
|
|
US5863560A
(en)
|
1996-09-11 |
1999-01-26 |
Virotex Corporation |
Compositions and methods for topical application of therapeutic agents
|
|
IN184589B
(pl)
|
1996-10-16 |
2000-09-09 |
Alza Corp |
|
|
DE19709704C2
(de)
|
1997-03-10 |
1999-11-04 |
Michael Georgieff |
Verwendung einer flüssigen Präparation von Xenon zur intravenösen Verabreichung bei Einleitung und/oder Aufrechterhaltung der Anaesthesie
|
|
US5980936A
(en)
|
1997-08-07 |
1999-11-09 |
Alliance Pharmaceutical Corp. |
Multiple emulsions comprising a hydrophobic continuous phase
|
|
US6335335B2
(en)
|
1997-11-05 |
2002-01-01 |
Senju Pharmaceutical Co., Ltd. |
Prolonged-action eye drop
|
|
US5981607A
(en)
|
1998-01-20 |
1999-11-09 |
Allergan |
Emulsion eye drop for alleviation of dry eye related symptoms in dry eye patients and/or contact lens wearers
|
|
EP0983037B1
(en)
|
1998-02-09 |
2003-05-02 |
MacroChem Corporation |
Antifungal nail lacquer
|
|
DE19861012A1
(de)
|
1998-03-18 |
1999-09-30 |
Pharm Pur Gmbh |
Behandlungsmittel für die Ophthalmologie
|
|
EP1105096B1
(en)
|
1998-08-19 |
2003-10-29 |
Skyepharma Canada Inc. |
Injectable aqueous dispersions of propofol
|
|
US6140374A
(en)
|
1998-10-23 |
2000-10-31 |
Abbott Laboratories |
Propofol composition
|
|
US6159977A
(en)
|
1998-11-16 |
2000-12-12 |
Astan, Inc. |
Therapeutic anti-fungal nail preparation
|
|
CN1232244C
(zh)
|
1999-02-08 |
2005-12-21 |
阿尔萨公司 |
稳定的非水性单相粘性载体及采用该载体的制剂
|
|
US7258869B1
(en)
|
1999-02-08 |
2007-08-21 |
Alza Corporation |
Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicle
|
|
AU3898700A
(en)
|
1999-03-15 |
2000-10-04 |
John Claude Krusz |
Treatment of acute headaches and chronic pain using rapidly-cleared anesthetic drug at sub-anesthetic dosages
|
|
US6177477B1
(en)
|
1999-03-24 |
2001-01-23 |
American Home Products Corporation |
Propofol formulation containing TRIS
|
|
US6239113B1
(en)
|
1999-03-31 |
2001-05-29 |
Insite Vision, Incorporated |
Topical treatment or prevention of ocular infections
|
|
DE19926890C1
(de)
|
1999-06-12 |
2000-07-27 |
Pharm Pur Gmbh |
Verwendung eines hochfluorierten oligomeren Alkans in der Ophthalmologie
|
|
DE19938668B4
(de)
|
1999-08-14 |
2006-01-26 |
Bausch & Lomb Inc. |
Tränenersatzmittel
|
|
US6528086B2
(en)
|
1999-09-28 |
2003-03-04 |
Zars, Inc. |
Methods and apparatus for drug delivery involving phase changing formulations
|
|
JP2001158734A
(ja)
|
1999-12-02 |
2001-06-12 |
Lion Corp |
眼科用組成物及びソフトコンタクトレンズに対する吸着抑制方法
|
|
US20030018044A1
(en)
|
2000-02-18 |
2003-01-23 |
Peyman Gholam A. |
Treatment of ocular disease
|
|
DE10024413A1
(de)
|
2000-05-19 |
2001-12-06 |
Mika Pharma Gmbh |
Pharmazeutische und/oder kosmetische Zubereitung
|
|
US6399087B1
(en)
|
2000-12-20 |
2002-06-04 |
Amphastar Pharmaceuticals, Inc. |
Propofol formulation with enhanced microbial inhibition
|
|
US20030027833A1
(en)
|
2001-05-07 |
2003-02-06 |
Cleary Gary W. |
Compositions and delivery systems for administration of a local anesthetic agent
|
|
JP4806162B2
(ja)
|
2001-09-04 |
2011-11-02 |
トロムスドルフ ゲーエムベーハー ウント コンパニー カーゲー アルツナイミッテル |
爪の成長の機能障害および疾患を治療するための硬膏
|
|
US20040033228A1
(en)
|
2002-08-16 |
2004-02-19 |
Hans-Juergen Krause |
Formulation of human antibodies for treating TNF-alpha associated disorders
|
|
US7074827B2
(en)
|
2002-10-24 |
2006-07-11 |
Sucampo Ag (Usa) Inc. |
Method for treating ocular hypertension and glaucoma
|
|
ES2541488T3
(es)
|
2003-08-25 |
2015-07-21 |
Foamix Pharmaceuticals Ltd. |
Espuma farmacéutica penetrante
|
|
US20050079210A1
(en)
|
2003-10-09 |
2005-04-14 |
Gupta Shyam K. |
Liposomal delivery system for topical pharmaceutical, cosmeceutical, and cosmetic ingredients
|
|
EP1670433B1
(en)
|
2003-10-10 |
2011-11-23 |
Antares Pharma IPL AG |
Transdermal pharmaceutical formulation for minimizing skin residues
|
|
EP1684724A4
(en)
|
2003-11-19 |
2008-04-02 |
Barnes Jewish Hospital |
IMPROVED DRUG DELIVERY
|
|
GB0408164D0
(en)
|
2004-04-13 |
2004-05-19 |
Immune Targeting Systems Ltd |
Antigen delivery vectors and constructs
|
|
ES2387619T3
(es)
|
2004-04-19 |
2012-09-27 |
Centre National De La Recherche Scientifique (Cnrs) |
Suplementos de tensioactivos pulmonares
|
|
US20050288196A1
(en)
|
2004-06-08 |
2005-12-29 |
Ocularis Pharma, Inc. |
Silicone polymer contact lens compositions and methods of use
|
|
US7063241B2
(en)
|
2004-06-10 |
2006-06-20 |
Allergan, Inc. |
Dispensing tip
|
|
WO2006007510A1
(en)
|
2004-07-01 |
2006-01-19 |
Schepens Eye Research |
Compositions and methods for treating eye disorders and conditions
|
|
US7740875B2
(en)
|
2004-10-08 |
2010-06-22 |
Mediquest Therapeutics, Inc. |
Organo-gel formulations for therapeutic applications
|
|
US20060078580A1
(en)
|
2004-10-08 |
2006-04-13 |
Mediquest Therapeutics, Inc. |
Organo-gel formulations for therapeutic applications
|
|
EP1688161A1
(en)
|
2004-11-02 |
2006-08-09 |
Switch Biotech Aktiengesellschaft |
Use of pirlindole for the treatment of diseases which are characterized by proliferation of t-lymphocytes and/or hyperproliferation of keratinocytes in particular atopic dermatitis and psoriasis
|
|
US7851504B2
(en)
|
2005-03-16 |
2010-12-14 |
Allergan, Inc. |
Enhanced bimatoprost ophthalmic solution
|
|
GB0511499D0
(en)
|
2005-06-06 |
2005-07-13 |
Medpharm Ltd |
Topical ungual formulations
|
|
ES2318802T3
(es)
|
2005-08-05 |
2009-05-01 |
BHARAT SERUMS & VACCINES LTD. |
Composiciones de emulsion de propofol intravenosas que tienen eficacia conservante.
|
|
FR2892023B1
(fr)
|
2005-10-14 |
2009-09-25 |
Galderma Sa |
Composition pharmaceutique a base d'amorolfine et d'agent filmogene hydrosoluble pour application ungueale et peri-ungueale
|
|
DE102005055811A1
(de)
|
2005-11-23 |
2007-05-31 |
Novaliq Gmbh |
Verwendung einer Zusammensetzung zur Konservierung von Organen und Gliedmaßen
|
|
TWI376239B
(en)
|
2006-02-01 |
2012-11-11 |
Andrew Xian Chen |
Vitamin e succinate stabilized pharmaceutical compositions, methods for the preparation and the use thereof
|
|
AR062046A1
(es)
|
2006-07-25 |
2008-08-10 |
Osmotica Pharmaceutical Argentina S A |
Soluciones oftalmicas
|
|
CA2664879C
(en)
|
2006-09-29 |
2015-03-24 |
Surmodics, Inc. |
Biodegradable ocular implants and methods for treating ocular conditions
|
|
KR20090087917A
(ko)
|
2006-12-07 |
2009-08-18 |
썬 파마 어드밴스트 리서치 컴패니 리미티드 |
마이크로리터량의 액체를 방울의 형태로 분배하기 위한 계량된 방울 병
|
|
FR2918891B1
(fr)
|
2007-07-20 |
2009-09-25 |
Thea Sa Lab |
Solution ophtalmique a base de prostaglandines sans conservateur
|
|
DE102007055046A1
(de)
|
2007-11-19 |
2009-05-28 |
Fluoron Gmbh |
Infusionslösung
|
|
WO2009120881A1
(en)
|
2008-03-26 |
2009-10-01 |
Eric Donnenfeld |
Methods for improving lid margin and tear film function and treatment of lid margin desease using tetracycline family antibiotics
|
|
DK2110126T3
(da)
|
2008-04-18 |
2012-02-27 |
Novaliq Gmbh |
Inhalations- og instillationsanvendelse af semifluorerede alkaner som aktiv bestanddel-bærere inden for det intrapulmonale område
|
|
US20100006600A1
(en)
|
2008-07-14 |
2010-01-14 |
Dascanio Gustavo A |
Fluid dispenser including hydrophobic ring
|
|
JP2012509737A
(ja)
|
2008-11-26 |
2012-04-26 |
サーモディクス，インコーポレイティド |
埋め込み式の眼薬送達器具および眼薬送達方法
|
|
US8501800B2
(en)
|
2009-03-05 |
2013-08-06 |
Insite Vision Incorporated |
Controlled-release ophthalmic vehicles
|
|
IT1393419B1
(it)
|
2009-03-19 |
2012-04-20 |
Medivis S R L |
Composizioni oftalmiche a base di acidi grassi polinsaturi omega-3 e omega-6.
|
|
WO2010146536A1
(en)
|
2009-06-18 |
2010-12-23 |
Koninklijke Philips Electronics N.V. |
Suspension of particles with drug
|
|
JP5549669B2
(ja)
|
2009-06-25 |
2014-07-16 |
ライオン株式会社 |
眼科用組成物、ドライアイ治療剤及びビタミンａの安定化方法
|
|
JP5736635B2
(ja)
|
2009-06-25 |
2015-06-17 |
ライオン株式会社 |
ドライアイ治療剤
|
|
DE102010027315A1
(de)
|
2009-07-24 |
2011-01-27 |
Mika Pharma Gesellschaft Für Die Entwicklung Und Vermarktung Pharmazeutischer Produkte Mbh |
Verfahren zur Entwicklung einer als Schaum auf die Haut zu applizierende flüssige Zusammensetzung sowie eine topisch applizierbare Zusammensetzung
|
|
EP2332525A1
(en)
|
2009-11-23 |
2011-06-15 |
Novaliq GmbH |
Pharmaceutical composition comprising propofol
|
|
EP2335735A1
(en)
|
2009-12-14 |
2011-06-22 |
Novaliq GmbH |
Pharmaceutical composition for treatment of dry eye syndrome
|
|
US20110223208A1
(en)
|
2010-03-09 |
2011-09-15 |
Beth Hill |
Non-Aqueous High Concentration Reduced Viscosity Suspension Formulations
|
|
KR101656121B1
(ko)
|
2010-03-17 |
2016-09-08 |
노바리크 게엠베하 |
안압 증가를 치료하기 위한 약학 조성물
|
|
DE102010022567A1
(de)
|
2010-06-02 |
2011-12-08 |
Fluoron Gmbh |
Zubereitung
|
|
EP2444063A1
(en)
|
2010-10-20 |
2012-04-25 |
Novaliq GmbH |
Liquid pharmaceutical compositions for the delivery of active ingredients
|
|
EP2462921A1
(en)
|
2010-11-11 |
2012-06-13 |
Novaliq GmbH |
Liquid pharmaceutical compositions for the treatment of a posterior eye disease
|
|
CA2819988C
(en)
|
2011-01-04 |
2019-11-12 |
Novaliq Gmbh |
O/w-emulsions comprising semifluorinated alkanes
|
|
EP2714008B1
(en)
|
2011-05-25 |
2016-12-14 |
Novaliq GmbH |
Pharmaceutical composition for administration to nails
|
|
PT2714010T
(pt)
|
2011-05-25 |
2017-05-05 |
Novaliq Gmbh |
Composição farmacêutica tópica à base de alcanos semifluorados
|
|
CA2862974C
(en)
|
2012-01-23 |
2021-11-16 |
Novaliq Gmbh |
Stabilised protein compositions based on semifluorinated alkanes
|
|
US9549966B2
(en)
|
2012-02-21 |
2017-01-24 |
Massachusetts Eye & Ear Infirmary |
Inflammatory eye disorders
|
|
US9878000B2
(en)
|
2012-06-20 |
2018-01-30 |
University Of Waterloo |
Mucoadhesive nanoparticle composition comprising immunosuppresant and methods of use thereof
|
|
CN113679697A
(zh)
|
2012-09-12 |
2021-11-23 |
诺瓦利克有限责任公司 |
包含半氟化烷烃的混合物的组合物
|
|
CA2883003C
(en)
|
2012-09-12 |
2021-11-16 |
Novaliq Gmbh |
Semifluorinated alkane compositions
|
|
EP2783703A1
(en)
|
2013-03-25 |
2014-10-01 |
B. Braun Melsungen AG |
Semifluorocarbon compound containing contrast agent
|
|
ES2687094T3
(es)
|
2013-07-23 |
2018-10-23 |
Novaliq Gmbh |
Composiciones estabilizadas de anticuerpos
|
|
WO2015153469A1
(en)
|
2014-03-31 |
2015-10-08 |
Amcor Limited |
Controlled release container
|
|
EP2944324A1
(de)
|
2014-05-13 |
2015-11-18 |
LTS LOHMANN Therapie-Systeme AG |
Verwendung von semifluorierten Alkanen in transdermalen therapeutischen Systemen
|
|
CN106572941B
(zh)
|
2014-08-13 |
2020-06-23 |
佛罗里达大学研究基金会股份有限公司 |
从眼药水中去除防腐剂
|
|
DE202016008738U1
(de)
|
2015-09-30 |
2019-04-09 |
Novaliq Gmbh |
Semifluorierte Verbindungen und ihre Zusammensetzungen
|
|
DK3722274T3
(da)
|
2015-09-30 |
2023-09-11 |
Novaliq Gmbh |
2-perfluorbutylpentan til oftalmisk indgivelse
|
|
KR20190003997A
(ko)
|
2016-06-01 |
2019-01-10 |
해롤드 리차드 헬스트롬 |
부교감 신경제와 항교감 신경제를 이용한 안구 건조증의 치료
|
|
ES2763121T3
(es)
|
2016-06-23 |
2020-05-27 |
Novaliq Gmbh |
Método de administración tópica
|
|
US10813976B2
(en)
|
2016-09-23 |
2020-10-27 |
Novaliq Gmbh |
Ophthalmic compositions comprising ciclosporin
|
|
AU2017333420A1
(en)
|
2016-09-28 |
2019-04-04 |
Novaliq Gmbh |
Compositions comprising a cannabinoid receptor binding ligand
|
|
AU2017380769B2
(en)
|
2016-12-22 |
2023-12-21 |
Novaliq Gmbh |
Compositions comprising tacrolimus for the treatment of intraocular inflammatory eye diseases
|
|
ES2965883T3
(es)
|
2016-12-23 |
2024-04-17 |
Novaliq Gmbh |
Composición oftálmica para el tratamiento de la enfermedad del ojo seco
|
|
WO2018193093A1
(en)
|
2017-04-21 |
2018-10-25 |
Novaliq Gmbh |
Iodine compositions
|
|
EP3618782B1
(en)
|
2017-05-06 |
2021-05-26 |
Novaliq GmbH |
Drop dispenser
|
|
US11278503B2
(en)
|
2017-05-12 |
2022-03-22 |
Novaliq Gmbh |
Pharmaceutical compositions comprising semifluorinated alkanes for the treatment of contact lense-related conditions
|
|
CA3076776A1
(en)
|
2017-09-27 |
2019-04-04 |
Novaliq Gmbh |
Ophthalmic compositions comprising latanoprost for use in the treatment of ocular diseases
|
|
CN120022260A
(zh)
|
2017-10-04 |
2025-05-23 |
诺瓦利克有限责任公司 |
包含f6h8的眼用组合物
|
|
WO2019166631A1
(en)
|
2018-03-02 |
2019-09-06 |
Novaliq Gmbh |
Pharmaceutical compositions comprising nebivolol
|
|
CA3091313A1
(en)
|
2018-03-28 |
2019-10-03 |
Novaliq Gmbh |
Pharmaceutical composition comprising timolol
|
|
EP3784246A1
(en)
|
2018-04-27 |
2021-03-03 |
Novaliq GmbH |
Ophthalmic compositions comprising tafluprost for the treatment of glaucoma
|
|
SG11202102818YA
(en)
|
2018-09-22 |
2021-04-29 |
Novaliq Gmbh |
Ophthalmic compositions for treatment of ocular surface damage and symptoms of dryness
|
|
AU2019358249B2
(en)
|
2018-10-12 |
2024-02-22 |
Novaliq Gmbh |
Ophthalmic composition for treatment of dry eye disease
|
|
SG11202104350RA
(en)
|
2018-11-27 |
2021-05-28 |
Novaliq Gmbh |
Semifluorinated alkane compositions comprising omega-3 fatty acid ethyl esters
|
|
WO2020152046A1
(en)
|
2019-01-21 |
2020-07-30 |
Novaliq Gmbh |
Pharmaceutical composition for the treatment of ocular neovascularisation
|
|
US20220226426A1
(en)
|
2019-05-24 |
2022-07-21 |
Novaliq Gmbh |
Ophthalmic composition for the treatment of ocular allergy
|